Background: The hydatid cyst is unique and localized in the right lobe of the liver in 65%. The most frequent extrahepatic locations are the lungs, the spleen and the peritoneum. Liver (55-70%) is the obvious first site after entry through the gut and passage in the portal circulation. Most cysts tend to be located in the right lobe. Hence this study has been undertaken to study various types of clinical presentations and different modalities of treatment.
Objectives: To study the various types of clinical presentation of Hydatid cyst of liver and its different modalities of management and To analyze mortality and morbidity due to Hydatid cyst of liver, To study the commonest causative species of Echinococcosis.
Materials and Methods: The patients attended surgical OPD and got admitted with hydatid cyst of Liver during the study period. Patients presenting with varying gastrointestinal symptoms and signs, and symptoms of space occupying lesions of liver like pain abdomen, obstructive jaundice, mass per abdomen, patients with complications due to rupture of hydatid cyst.A total of 60 cases of hydatid cyst of Liver.
Results and Discussion: Out of 60 patients, 48 patients underwent surgery (80%). 42 of them underwent complete pericystectomy (87.5%) and 6 patients underwent incomplete pericystectomy(12.5%). Patients recovered uneventfully in post operative period. On subsequent follow up 4 patients were found to have residual disease. One of these patients had undergone complete pericystectomy for disseminated intra abdominal hydatidosis, the other had undergone partial pericystectomy for solitary hydatid cyst in right lobe of liver near the posterior surface.
Conclusion: Hydatid disease of liver is a complex and dynamic disease with an evolving phase when the cysts grow, followed by an involution process during which the parasite is gradually dying off leaving behind a solidified, often calcified cyst or a scar. Each successive active cyst stage carries its own risks for serious and even life threatening complications. For complex diseases, no “one size fits all” approach is to be adopted and a stage-specific and resource-specific approach would be deemed necessary.